Harbin Medical University Clinical Trials
Sponsors / Harbin Medical University
ClinicalTrials.gov lists 71 trials for which Harbin Medical University is named as lead sponsor. Of these, 11 are recruiting, 4 are active without new recruitment, and 13 have completed. The registry records 5 terminated or withdrawn trials for Harbin Medical University. The most common reasons cited for termination include slow or insufficient recruitment. Planned participant enrollment across these trials sums to 33,821. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
71
Total Trials
11
Recruiting
4
Other Active
13
Completed
5
Terminated / Withdrawn
33,821
Total Enrollment
Termination reasons: Recruitment80% · Other20%
Recent Terminations
- Gastric Cancer"we are working on a larger similar multicenter cinical trials as a participant.so in order to avoid conflicts of interest, we have to suspended this project."
- Acute Myocardial Infarction"Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial."
- Coronary Artery Disease"Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial."
- Coronary Artery Disease"Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial."
- Coronary Heart Disease"Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial."
Active Trials (4 total)
- NCT07471815
- NCT06817512
- NCT07163455
- NCT06489119
- Breast Cancer PHASE2NCT06599216
- NCT06422702
- NCT06348992
- NCT06016608
- NCT06154395
- NCT04912518
- Stroke NANCT06437587
- ADHD NANCT06553430
- NCT06449274
- Gastric Adenocarcinoma PHASE2NCT06196697
- NCT06365502